| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/APM.12674 |
| P698 | PubMed publication ID | 28407429 |
| P50 | author | Niels Høiby | Q12328808 |
| Laura Line | Q59544496 | ||
| Hannah Trøstrup Pedersen | Q59544534 | ||
| Kim Thomsen | Q86199056 | ||
| Peter Østrup Jensen | Q42574299 | ||
| Mette Kolpen | Q47503370 | ||
| Claus E Moser | Q58417725 | ||
| Christian J. Lerche | Q40066028 | ||
| P2860 | cites work | Extracellular DNA Required for Bacterial Biofilm Formation | Q22065541 |
| Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 | ||
| A component of innate immunity prevents bacterial biofilm development | Q24298499 | ||
| Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients | Q24551181 | ||
| Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia | Q59139142 | ||
| Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection | Q59139144 | ||
| Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection | Q59139146 | ||
| Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats | Q59139188 | ||
| Complement activation by Pseudomonas aeruginosa biofilms | Q59139208 | ||
| Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy | Q24650612 | ||
| Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum | Q24678466 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 | ||
| Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood | Q28294906 | ||
| Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration | Q28492742 | ||
| The reaction of no with superoxide | Q28611742 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| The acute respiratory distress syndrome | Q29615140 | ||
| Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis | Q30422695 | ||
| Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis | Q30479961 | ||
| Alarmins: awaiting a clinical response | Q30523797 | ||
| Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection | Q30742543 | ||
| Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin | Q30832118 | ||
| Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients | Q30842136 | ||
| Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum | Q30868724 | ||
| Migration inhibitory factor-related protein (MRP)8 and MRP14 are differentially expressed in free-electron laser and scalpel incisions | Q31084958 | ||
| Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions | Q33193706 | ||
| T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal | Q33774232 | ||
| Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils | Q33788110 | ||
| The clinical impact of bacterial biofilms | Q33870211 | ||
| Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulin | Q33880228 | ||
| Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds. | Q33881502 | ||
| Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: a retrospective study. | Q33927203 | ||
| Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents | Q34024546 | ||
| Impact of burden on granulocyte clearance of bacteria in a mouse thigh infection model | Q34151060 | ||
| Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth | Q34167016 | ||
| The evolution and genetics of innate immunity | Q34205534 | ||
| Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo | Q34268901 | ||
| Role of vegetation-associated protease activity in valve destruction in human infective endocarditis. | Q34429820 | ||
| The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing | Q34469399 | ||
| Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients | Q34481869 | ||
| Pulmonary oxidative stress response in young children with cystic fibrosis | Q42152011 | ||
| A novel terminal oxidase, cytochrome baa3 purified from aerobically grown Pseudomonas aeruginosa: it shows a clear difference between resting state and pulsed state | Q42157384 | ||
| Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens | Q42261747 | ||
| Nitric oxide metabolites in cystic fibrosis lung disease | Q42279678 | ||
| Distribution, organization, and ecology of bacteria in chronic wounds | Q42406600 | ||
| Flagellum-mediated biofilm defense mechanisms of Pseudomonas aeruginosa against host-derived lactoferrin | Q42561332 | ||
| Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis | Q43257270 | ||
| Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation. | Q43258679 | ||
| Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa | Q43264873 | ||
| Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst. | Q43492946 | ||
| Infections caused by Gram-positive bacteria: situation and challenges of treatment | Q43809735 | ||
| Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response | Q43904318 | ||
| Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis | Q44434322 | ||
| Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease | Q44570027 | ||
| Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent | Q45256199 | ||
| TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease | Q45277553 | ||
| Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model | Q45742361 | ||
| Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. | Q45743059 | ||
| A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. | Q45834194 | ||
| Pseudomonas aeruginosa quorum-sensing signal molecules interfere with dendritic cell-induced T-cell proliferation | Q46136577 | ||
| Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes | Q46149392 | ||
| Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience | Q46436058 | ||
| Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. | Q46681339 | ||
| Endocarditis pathogen promotes vegetation formation by inducing intravascular neutrophil extracellular traps through activated platelets | Q46796272 | ||
| Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen | Q46921876 | ||
| Proteomic analysis of agar gel-entrapped Pseudomonas aeruginosa | Q47279583 | ||
| Differential cytokine profile in children with cystic fibrosis | Q47799334 | ||
| Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. | Q47946251 | ||
| The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa | Q48078797 | ||
| Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms | Q49086146 | ||
| Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. | Q50452988 | ||
| A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus | Q50533915 | ||
| A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. | Q51515447 | ||
| Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. | Q51604372 | ||
| Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? | Q51806602 | ||
| Metchnikoff's Legacy in 2008. | Q53142153 | ||
| Infective endocarditis. | Q53905921 | ||
| Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. | Q53999657 | ||
| Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. | Q54406303 | ||
| Neutrophil signaling pathways activated by bacterial DNA stimulation. | Q54456426 | ||
| Membrane-Bound Respiratory Chain of Pseudomonas aeruginosa Grown Aerobically. A KCN-Insensitive Alternate Oxidase Chain and Its Energetics | Q54500066 | ||
| Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets | Q56987951 | ||
| Inflammatory markers in cystic fibrosis patients with transmissiblePseudomonas aeruginosa | Q57913738 | ||
| Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection | Q59139133 | ||
| IgY: a promising antibody for use in immunodiagnostic and in immunotherapy. | Q37677316 | ||
| The immune system vs. Pseudomonas aeruginosa biofilms | Q37767747 | ||
| Antimicrobial peptides: old molecules with new ideas | Q37967109 | ||
| Treatment of lung infection in patients with cystic fibrosis: current and future strategies | Q38058617 | ||
| Characterization of bacterial DNA binding to human neutrophil surface. | Q38289260 | ||
| The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes | Q38298705 | ||
| Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection | Q38479070 | ||
| Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone | Q38484721 | ||
| ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. | Q39055760 | ||
| Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis | Q39519011 | ||
| Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis | Q40253218 | ||
| Protein Network of the Pseudomonas aeruginosa Denitrification Apparatus. | Q40333924 | ||
| IgY: clues to the origins of modern antibodies. | Q40404330 | ||
| Pathogenesis of cystic fibrosis | Q40486086 | ||
| S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus | Q40711991 | ||
| Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers | Q40721665 | ||
| Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice | Q40743107 | ||
| The phagocytic fitness of leucopatches may impact the healing of chronic wounds | Q40810674 | ||
| Shear-Resistant Binding to von Willebrand Factor Allows Staphylococcus lugdunensis to Adhere to the Cardiac Valves and Initiate Endocarditis | Q40840729 | ||
| The role of platelets in antimicrobial host defense | Q40875582 | ||
| Low efficacy of tobramycin in experimental Staphylococcus aureus endocarditis. | Q40964756 | ||
| Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model | Q41035476 | ||
| Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection | Q41515111 | ||
| Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. | Q41861048 | ||
| Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent | Q34501431 | ||
| Innate and Adaptive Immunity in Cystic Fibrosis | Q34512982 | ||
| Mucus clearance as a primary innate defense mechanism for mammalian airways | Q34551378 | ||
| Antibiotic allergy in cystic fibrosis | Q34558027 | ||
| Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa | Q34623469 | ||
| Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model | Q34736543 | ||
| Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff | Q34787221 | ||
| Plasticity of CD4+ T cell lineage differentiation. | Q34982725 | ||
| T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis | Q35108903 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin | Q35949774 | ||
| Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses | Q36018223 | ||
| The expression and roles of Toll-like receptors in the biology of the human neutrophil. | Q36053220 | ||
| Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins | Q36221549 | ||
| Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis | Q36403016 | ||
| Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis | Q36488777 | ||
| Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry | Q36496456 | ||
| Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model | Q36826903 | ||
| Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa | Q36850139 | ||
| Neutrophil extracellular traps - the dark side of neutrophils | Q36867309 | ||
| Energy metabolism of human neutrophils during phagocytosis | Q36985938 | ||
| Role of polysaccharides in Pseudomonas aeruginosa biofilm development | Q36991638 | ||
| Th17 T cells: linking innate and adaptive immunity | Q37006577 | ||
| Transcriptional regulation of Th17 cell differentiation | Q37021803 | ||
| Osteomyelitis and the role of biofilms in chronic infection | Q37032879 | ||
| Why chronic wounds will not heal: a novel hypothesis | Q37062464 | ||
| Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography | Q37144524 | ||
| Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. | Q37209089 | ||
| Association between pulmonary function and sputum biomarkers in cystic fibrosis | Q37287157 | ||
| Neutrophils in cystic fibrosis. | Q37356771 | ||
| Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. | Q37437092 | ||
| Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells | Q37447209 | ||
| Periodontitis: an archetypical biofilm disease | Q37572197 | ||
| Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation | Q37633213 | ||
| P433 | issue | 4 | |
| P921 | main subject | biofilm | Q467410 |
| P304 | page(s) | 320-338 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Acta Pathologica et Microbiologica Scandinavica | Q15756643 |
| P1476 | title | Biofilms and host response - helpful or harmful | |
| P478 | volume | 125 |
| Q64101186 | Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditis |
| Q89578524 | Bacterial Biofilm and its Role in the Pathogenesis of Disease |
| Q88541024 | Chronic biofilm-based infections: skewing of the immune response |
| Q90346593 | Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), T |
| Q89948598 | Host responses to mucosal biofilms in the lung and gut |
| Q91940081 | Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing |
| Q61446623 | Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species |
| Q55317638 | Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms. |
| Q52323573 | Nanocoatings for Chronic Wound Repair-Modulation of Microbial Colonization and Biofilm Formation. |
| Q90632767 | Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease-Is There Cause for Consideration? |
| Q47640423 | Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections |
| Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
| Q64973509 | Streptococcus sanguinis biofilm formation & interaction with oral pathogens. |
| Q64263464 | The Detection of Bacteria and Matrix Proteins on Clinically Benign and Pathologic Implants |
| Q90721132 | The Long-Term Persistence of Borrelia burgdorferi Antigens and DNA in the Tissues of a Patient with Lyme Disease |
| Q57279408 | The Role of Functional Amyloids in Bacterial Virulence |
| Q90496401 | The origin of extracellular DNA in bacterial biofilm infections in vivo |
| Q92190829 | Transcriptome, Phenotypic, and Virulence Analysis of Streptococcus sanguinis SK36 Wild Type and Its CcpA-Null Derivative (ΔCcpA) |
| Q47119043 | Unveiling and Characterizing Early Bilateral Interactions between Biofilm and the Mouse Innate Immune System |
Search more.